Methamphetamine Toxicities and Clinical Management
Authors:
- 28 November 2023
- journal article
- review article
- Published by Massachusetts Medical Society in NEJM Evidence
- Vol. 2 (12)
Abstract
Methamphetamine Toxicities and Clinical ManagementMethamphetamine increases the release and blocks the uptake of norepinephrine, serotonin, and dopamine. This article reviews the morbidity and mortality associated with methamphetamine use and discusses prevention and treatment strategies.Keywords
This publication has 74 references indexed in Scilit:
- Amphetamine-induced psychosis - a separate diagnostic entity or primary psychosis triggered in the vulnerable?BMC Psychiatry, 2012
- Cumulative exposure to stimulants and immune function outcomes among HIV-positive and HIV-negative men in the Multicenter AIDS Cohort StudyInternational Journal of STD & AIDS, 2012
- Mirtazapine to Reduce Methamphetamine UseArchives of General Psychiatry, 2011
- Characterizing methamphetamine withdrawal in recently abstinent methamphetamine users: a pilot field studyThe American Journal of Drug and Alcohol Abuse, 2010
- Withdrawal symptoms in abstinent methamphetamine‐dependent subjectsAddiction, 2010
- Modafinil Administration Improves Working Memory in Methamphetamine‐Dependent Individuals Who Demonstrate Baseline ImpairmentThe American Journal on Addictions, 2010
- Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependenceDrug and Alcohol Dependence, 2008
- Methamphetamine use and infectious disease‐related behaviors in men who have sex with men: implications for interventionsAddiction, 2007
- The prevalence of psychotic symptoms among methamphetamine usersAddiction, 2006
- Quantitative Drug Levels in Stimulant Psychosis: Relationship to Symptom Severity, Catecholamines and HyperkinesiaThe American Journal on Addictions, 2004